Barrie Haigh
Plus aucun poste en cours
Profil
Barrie Haigh is the founder of Innovex, Inc. which was founded in 1979.
He worked as a Marketing Director & General Manager at Organon Pharma (UK) Ltd.
and as a Non-Executive Director at Pharmacy2U Ltd.
He also worked as a Principal at the Royal Pharmaceutical Society of Great Britain and as a Member at the British Pharmacopoeia.
Anciens postes connus de Barrie Haigh
| Sociétés | Poste | Fin |
|---|---|---|
| British Pharmacopoeia | Corporate Officer/Principal | - |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | - |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Sales & Marketing | - |
Innovex, Inc.
 Innovex, Inc. Computer PeripheralsElectronic Technology Innovex, Inc. provides circuit interconnect solutions to original equipment manufacturers in the electronics industry. It offers circuit applications and services from initial design, development, and prototype to fabrication, assembly, and test. The company was founded in 1972 and is headquartered in Plymouth, MN. ^ | Fondateur | - |
Pharmacy2U Ltd.
 Pharmacy2U Ltd. Drugstore ChainsRetail Trade Pharmacy2U Ltd. provides online pharmacy services. The firm offers private online doctors, NHS, private prescriptions, over-the-counter medicines, health, beauty products, fine fragrances, and skincare products. The company was founded by Daniel Mark Lee and Steven John Dobson on July 8, 1999 and is headquartered in Leeds, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pharmacy2U Ltd.
Pharmacy2U Ltd. Drugstore ChainsRetail Trade Pharmacy2U Ltd. provides online pharmacy services. The firm offers private online doctors, NHS, private prescriptions, over-the-counter medicines, health, beauty products, fine fragrances, and skincare products. The company was founded by Daniel Mark Lee and Steven John Dobson on July 8, 1999 and is headquartered in Leeds, the United Kingdom. | Retail Trade |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Innovex, Inc.
Innovex, Inc. Computer PeripheralsElectronic Technology Innovex, Inc. provides circuit interconnect solutions to original equipment manufacturers in the electronics industry. It offers circuit applications and services from initial design, development, and prototype to fabrication, assembly, and test. The company was founded in 1972 and is headquartered in Plymouth, MN. ^ | Electronic Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
| British Pharmacopoeia |
